General Practice · Los Angeles, CA
NPI
1841489440
Since 2007
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
11900 Avalon Blvd, #100
Los Angeles, CA, 90061
Phone (323) 756-1317
Medicare paid, 2024
$25.0M
49,409 services
Medicare patients, 2024
2,020
Average age 74
Drug cost, 2024
$4.1M
15,928 prescriptions
Company payments, 2025
$5,614
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jack Azad was code Q4236 (carepatch, per square centimeter), 9,695 times for 51 patients. In total Jack Azad billed 49,409 services in 89 codes, and Medicare paid $25.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q4236 Carepatch, per square centimeter | Office | 9,695 | 51 | $629.23 | $6.1M |
| Q4271 Complete ft, per square centimeter | Office | 5,038 | 61 | $1,325.79 | $6.7M |
| 99349 Home E&M - New and Established | Office | 3,703 | 530 | $102.43 | $379K |
| 93040 Electrocardiogram | Office | 2,358 | 614 | $9.71 | $23K |
| 92540 Vision, Hearing, and Speech Services | Office | 2,346 | 611 | $81.27 | $191K |
| 92546 Vision, Hearing, and Speech Services | Office | 1,689 | 602 | $110.99 | $187K |
| 93923 Duplex Scan - Extremity Arteries | Office | 1,613 | 593 | $102.73 | $166K |
| 97610 Skin | Office | 1,270 | 106 | $394.11 | $501K |
| 95921 Electrical Nerve Conductivity | Office | 1,227 | 566 | $65.91 | $81K |
| 95923 Electrical Nerve Conductivity | Office | 1,225 | 564 | $94.61 | $116K |
| 99309 SNF E&M | Office | 1,191 | 205 | $88.14 | $105K |
| 11043 Debridement | Office | 1,181 | 257 | $193.93 | $229K |
| 99348 Home E&M - New and Established | Office | 1,123 | 477 | $60.94 | $68K |
| 99309 SNF E&M | Facility | 867 | 162 | $87.74 | $76K |
| 11042 Debridement | Office | 707 | 196 | $92.97 | $66K |
By year: 2022 $9.4M for 41,790 services; 2023 $23.6M for 50,766 services; 2024 $25.0M for 49,409 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 143 | 113 | $8.65 | $1,237 |
Medicare prescription drug claims, 2024
In 2024, the drug Jack Azad prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,273 prescriptions and refills. In total Jack Azad wrote 15,928 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,273 | 2,975 | 363 | $19K |
| Diclofenac Sodium Generic | 601 | 623 | 125 | $11K |
| Xarelto Rivaroxaban | 421 | 1,008 | 110 | $549K |
| Gabapentin Generic | 403 | 929 | 132 | $7,068 |
| Amlodipine Besylate Generic | 386 | 623 | 95 | $2,741 |
| Levothyroxine Sodium Generic | 317 | 506 | 73 | $4,556 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 306 | 852 | 93 | $4,926 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 269 | 745 | 82 | $447K |
| Losartan Potassium Generic | 267 | 555 | 83 | $3,814 |
| Metformin Hcl Generic | 248 | 369 | 71 | $2,902 |
| Omeprazole Generic | 246 | 562 | 91 | $2,231 |
| Tamsulosin Hcl Generic | 243 | 414 | 71 | $4,074 |
| Pantoprazole Sodium Generic | 239 | 536 | 72 | $3,337 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 234 | 635 | 72 | $328K |
| Furosemide Generic | 205 | 350 | 64 | $925 |
Brand drugs: 3,306 claims; generic drugs: 12,319 claims; opioid claims: 413.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jack Azad $5,614 ($5,614 in general payments such as food, travel and fees) from 26 companies. The largest payer was Alkermes, Inc. with $947.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 30 | $947 |
| Amgen Inc. AMGN | 20 | $872 |
| Abbvie Inc. ABBV | 26 | $470 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $457 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 18 | $418 |
| Ardelyx, Inc. ARDX | 9 | $379 |
| Novo Nordisk Inc NVO | 11 | $319 |
| Pfizer Inc. PFE | 19 | $306 |
| GlaxoSmithKline, LLC. GSK | 9 | $193 |
| Lilly USA, LLC LLY | 7 | $179 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.